2nd RNA Editing Summit 2020

Pharma Phorum

The only industry-led meeting showcasing the recent development of RNA editing mechanisms and dedicated to realizing the research and therapeutics opportunity of RNA editing as quickly as possible. The post 2nd RNA Editing Summit 2020 appeared first on.

RNA 52

3rd RNA-Targeted Drug Discovery Summit

Pharma Phorum

The world of drug discovery and chemical probes is still protein-centric and developing highly selective small molecules targeting RNA is often considered to be an insurmountable challenge. Why You Should Attend the RNA- Targeted Drug Discovery Summit.

RNA 52

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Locanabio’s RNA-Targeting Gene Therapy May Offer Durable Response for DM1 Patients

BioSpace

RNA-binding proteins are emerging as the next generation of molecular medicine

2020 RNA Therapies in Oncology Analytical Tool – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “RNA Therapies in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering. RNA Therapies in Oncology: Analytical Tool is the must have handbook for any business developer, BI/CI operative or clinical developer who needs to be on … Continue reading → Business Wire

RNA 40

UMD researchers develop tools to sharpen 3D view of large RNA molecules

Scienmag

New technique breaks through a technology roadblock that limited RNA imaging for 50 years Credit: Kwaku Dayie/University of Maryland University of Maryland scientists have developed a method to determine the structures of large RNA molecules at high resolution.

RNA 56

NSF backs bioinformatics approach to understanding plant RNA modifications

Scienmag

Led by Boyce Thompson Institute’s Andrew Nelson, four partners will identify RNA modifications and develop resources that may lead to hardier crops Credit: Photo credit: Anna Nelson Dittrich ITHACA, NY, August 4, 2020 — RNA perform a variety of functions in cells, helping with everything from regulating genes to building proteins.

#news #biotech Breast cancer study uncovers new RNA targets for treatment and diagnostics

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Breast cancer study uncovers new RNA targets for treatment and diagnostics.Breast cancer study uncovers new RNA targets for treatment and diagnostics arlene.weintraub Mon, 10/19/2020 – 08:41 from … Continue reading → #news

RNA 40

Small RNA as a central player in infections

Scienmag

Credit: (Image: Chair of Molecular Infection Biology II / University of Wuerzburg / SCIGRAPHIX) More than half of the world’s population carries the bacterium Helicobacter pylori in their stomach mucosa.

Small molecule targets SARS-CoV-2 RNA for destruction

Scienmag

Now, researchers reporting in ACS Central Science have identified small molecules that target a structure within the RNA genome […]. SARS-CoV-2, the virus responsible for COVID-19, has wreaked havoc on health care systems, economies and everyday lives worldwide. Scientists are fighting back with multiple strategies, including vaccines, repurposed drugs developed for other diseases and brand-new therapies.

RNA 43

Untangling the Body’s Smart Sensors: What RNA Binding Proteins Can Tell Us About Gene Regulation

BioSpace

I certainly can’t, but Eclipse BioInnovations, a San Diego-based biotech start-up, is aiming to do just that for RNA therapeutics Can you imagine organizing more than 10 terabytes of data into a useful network of information, like creating Google maps from scratch?

RNA 91

Global RNA-interference (RNAi) Market Outlook 2020-2025: Improving Synthetic Delivery Carriers and Chemical Modifications to RNA – ResearchAndMarkets.com

BioTech 365

DUBLIN–(BUSINESS WIRE)–The “RNA-interference (RNAi) Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The RNA-interference (RNAi) market is expected to witness a CAGR of 10.12% during the forecast period.

RNA 40

#news #biotech European neuro RNA biotech Vico Therapeutics nabs Bayer alum as CMO

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: European neuro RNA biotech Vico Therapeutics nabs Bayer alum as CMO.European neuro RNA biotech Vico Therapeutics nabs Bayer alum as CMO badams Thu, 10/01/2020 – 08:00 from … Continue reading → #news

RNA 40

MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-in-Class Activating RNA-Based Therapeutics

BioTech 365

RNA 52

?Arrakis Therapeutics Publishes Advanced Research Method To Systematically Identify RNA-Targeted Small Molecules

BioTech 365

Technology platform tool, PEARL-seq™, identifies binding sites in RNA by integrating proprietary bioinformatics workflow with chemical biology techniques for the rational design of rSM therapeutics WALTHAM, Mass.–(BUSINESS

#news #biotech MiNA raises $30M to take small activating RNA into phase 2

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MiNA raises $30M to take small activating RNA into phase 2.MiNA raises $30M to take small activating RNA into phase 2 ntaylor Thu, 09/10/2020 – 05:15 from … Continue reading → #news

RNA 40

#news #biotech Outsmarting COVID-19 and other viruses by analyzing RNA in single cells

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Outsmarting COVID-19 and other viruses by analyzing RNA in single cells.Outsmarting COVID-19 and other viruses by analyzing RNA in single cells arlene.weintraub Fri, 08/21/2020 – 09:05 from … Continue reading → #news

RNA 40

Promega Heater Shaker Magnet LV 32 HSM 32 Sample DNA / RNA Purification

BioTech 365

AU $1,340.23End Date: Thursday Sep-10-2020 9:43:55 ESTBuy It Now for only: AU $1,340.23Buy It Now | Add to watch list Biotech365 : Promega Heater Shaker Magnet LV 32 HSM 32 Sample DNA / RNA Purification BioMarketplace You want to propose … Continue reading → #BioMarketplace #BioMarketplace_AU #Promega

RNA 43

#news #biotech ILC: GSK’s antisense hep B hopeful hits positives in midstage test, rivaling RNA therapies

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ILC: GSK’s antisense hep B hopeful hits positives in midstage test, rivaling RNA therapies.ILC: GSK’s antisense hep B hopeful hits positives in midstage test, rivaling RNA therapies … Continue reading → #news

RNA 40

Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins

BioTech 365

FRANKFURT, Germany–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy.

RNA 52

Shape Therapeutics to Present Groundbreaking Advances in ADAR-Mediated RNA Editing in Parkinson’s Disease at the Jefferies Gene Therapy and Editing Summit

BioTech 365

ShapeTX), a pre-clinical stage company with an industry-leading RNA targeting technology platform, announced today that Francois Vigneault, PhD., SEATTLE–(BUSINESS WIRE)–Shape Therapeutics, Inc.

RNA 52

NEW Thermo Invitrogen Qubit 4 DNA RNA Oligo Ion Protein Fluorometer w/Warranty

BioTech 365

$2,950.00End Date: Monday Aug-31-2020 14:55:52 PDTBuy It Now for only: $2,950.00Buy It Now | Add to watch list Biotech365 : NEW Thermo Invitrogen Qubit 4 DNA RNA Oligo Ion Protein Fluorometer w/Warranty BioMarketplace You want to propose your products or … Continue reading → #BioMarketplace #BioMarketplace_US #Invitrogen

RNA 40

#news #biotech Korro Bio hits the high notes with $91.5M series A to run its OPERA RNA platform

BioTech 365

series A to run its OPERA RNA platform.Korro Bio hits the high notes with $91.5M Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Korro Bio hits the high notes with $91.5M series A to run … Continue reading → #news

RNA 40

Moderna and Pfizer, having shown speed with coronavirus vaccines, see opportunity in seasonal flu

Bio Pharma Dive

Both companies believe the messenger RNA technology they're using in their coronavirus vaccines could be applied to create a better flu shot

RNA 178

Combining the Powers of Single Cell Sequencing and AI in Understanding Disease Biology and Drug Development

XTalks

Single cell RNA sequencing in particular has contributed the most to understanding the functional biology of a single cell in broader populations of cells, helping to highlight the presence of diverse cell populations within tissues and their distinct roles in disease.

BioNTech to buy manufacturing plant from Novartis to bolster vaccine supply

Bio Pharma Dive

The Novartis plant will help BioNTech and partner Pfizer make 750 million doses of their shot per year, and become one of the largest messenger RNA manufacturing sites in Europe

RNA 141

LabCorp Receives EUA from FDA for New High-Speed COVID-19 Test

BioSpace

The new high-speed test uses a high-throughput method comprising heat and technology to extract RNA from samples used for COVID-19 RT-PCR molecular testing

RNA 91

ATDBio and research team win Innovate UK grant

Pharma Times

The funds will be used to improve single-cell RNA sequencing

RNA 56

Strand Therapeutics’ mRNA Logic Circuits Enhance Gene Therapy’s Safety, Ease and Controllability

BioSpace

The company is genetically programming RNA not just to deliver a gene of interest, but to control the location, timing and intensity of therapeutic protein expression using mRNA-encoded logic circuits

RNA 100

MiNA Therapeutics Raises $30 Million, Looks to Propel Its Lead Candidate

BioSpace

The financing will be used by MiNA to advance the company’s pipeline of proprietary, first-in-class, small activating RNA therapeutics

RNA 60

Moffitt Cancer Center Sees Breakthrough in Latest Pan-Cancer Analysis

BioSpace

Through their work, they were able to determine that the protein, TAp63, appears to impact the level of RNA molecules within the body. This subsequently connects the activities of p53 and AKT, the altered genes in cancer

RNA 55

Deep learning takes on synthetic biology

Scienmag

Computational algorithms enable identification and optimization of RNA-based tools for myriad applications DNA and RNA have been compared to “instruction manuals” containing the information needed for living “machines” to operate.

RNA 43

Oncotarget: The role of miRNA-133b and its target gene SIRT1 in FAP-derived desmoid tumor

Scienmag

Volume 11, Issue 26 of Oncotarget reported that in this study the authors studied the differences in mi RNA expression between sporadic and FAP-associated Desmoid tumors using microarray confirmed by quantitative PCR.

RNA 56

Moderna to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020

BioTech 365

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 … Continue reading → Business Wire

RNA 52

A new strategy for siRNA stabilization by an artificial cationic oligosaccharide

Scienmag

Credit: TMIMS RNA interference is a gene regulatory mechanism in which the expression of specific genes is downregulated by endogenous microRNAs or by small interfering RNAs (siRNAs).

MiNA Therapeutics Appoints Peter Bains as Chief Business Officer

BioTech 365

LONDON–(BUSINESS WIRE)–MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced today the appointment of Peter Bains as Chief Business Officer (CBO), effective September 22, 2020.

RNA 52

Moderna to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference

BioTech 365

CAMBRIDGE, Mass.–(BUSINESS –(BUSINESS WIRE)–Moderna, Inc.,

RNA 52

Canada Exercises Increased Option for 20 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

BioTech 365

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics … Continue reading → Business Wire

RNA 52

Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH)

BioTech 365

Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients and Chiesi Farmaceutici S.p.A., CAMBRIDGE, Mass. & & PARMA, Italy–(BUSINESS WIRE)–Moderna, Inc.

RNA 52

Moderna Announces First Commercial Organization Outside North America in Switzerland

BioTech 365

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for … Continue reading → Business Wire

RNA 52

New drug candidate found for hand, foot and mouth disease

Scienmag

Targeting RNA with small molecules could pave the way for new antivirals Credit: Courtesy of the Hargrove lab DURHAM, N.C. — A study appearing next week in the journal Nature Communications offers some good news in the search for antiviral drugs for hard-to-treat diseases.

RNA 63